News + Filings Transactions
|
Knowles Julius
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Keros Therapeutics, Inc. | KROS | Grant | Stock Option (right to buy) | 10k | $48.79 | $487.9k | | 06/06/2023 |
| 06/01/2022 | Keros Therapeutics, Inc. | KROS | Grant | Stock Options (right to buy) | 8.3k | $32.95 | $273.3k | | 06/01/2022 |
| 01/05/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 419 | $57.23 | $24k | See footnote | 01/03/2022 |
| 01/05/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 271 | $57.23 | $15.5k | See footnote | 01/03/2022 |
| 01/05/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 1.4k | $58.20 | $78.9k | See footnote | 01/03/2022 |
| 01/05/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 886 | $58.20 | $51.6k | See footnote | 01/03/2022 |
| 01/05/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 667 | $59.00 | $39.4k | See footnote | 01/03/2022 |
| 01/05/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 435 | $59.00 | $25.7k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 794 | $54.95 | $43.6k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 524 | $54.95 | $28.8k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 2.1k | $56.10 | $119.2k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 1.4k | $56.10 | $77.6k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 1.7k | $56.95 | $97.2k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 1.1k | $56.95 | $63.4k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 4.2k | $57.99 | $240.7k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 2.7k | $57.99 | $156.8k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 3.4k | $58.86 | $198.2k | See footnote | 01/03/2022 |
| 01/04/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 2.2k | $58.86 | $129.2k | See footnote | 01/03/2022 |
| 01/03/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 3.7k | $56.82 | $209k | See footnote | 01/03/2022 |
| 01/03/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 2.4k | $56.82 | $136.7k | See footnote | 01/03/2022 |
| 01/03/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 5.1k | $57.83 | $294.6k | See footnote | 01/03/2022 |
| 01/03/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 3.3k | $57.83 | $191.9k | See footnote | 01/03/2022 |
| 01/03/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 5.2k | $58.96 | $308.7k | See footnote | 01/03/2022 |
| 01/03/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 3.4k | $58.96 | $201.2k | See footnote | 01/03/2022 |
| 01/03/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 249 | $59.40 | $14.8k | See footnote | 01/03/2022 |
| 01/03/2022 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 162 | $59.40 | $9.6k | See footnote | 01/03/2022 |
| 12/02/2021 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 90 | $54.67 | $4.9k | See footnote | 12/01/2021 |
| 12/02/2021 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 138 | $54.67 | $7.5k | See footnote | 12/01/2021 |
| 12/02/2021 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 5.7k | $53.86 | $307.3k | See footnote | 12/01/2021 |
| 12/02/2021 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 8.7k | $53.86 | $471.1k | See footnote | 12/01/2021 |
| 12/02/2021 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 4.2k | $53.17 | $220.9k | See footnote | 12/01/2021 |
| 12/02/2021 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 6.4k | $53.17 | $338.8k | See footnote | 12/01/2021 |
| 12/02/2021 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 52 | $52.00 | $2.7k | See footnote | 12/01/2021 |
| 12/02/2021 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 79 | $51.99 | $4.1k | See footnote | 12/01/2021 |
| 12/01/2021 | Keros Therapeutics, Inc. | KROS | Sale | Common Stock | 1k | $56.27 | $57.5k | See footnote | 12/01/2021 |
|
|